11-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]naphthalen-1-yl]-4-phenylindolo[2,1-b][1,3]benzothiazole
C51H32N4S — CID 164782197
Data last refreshed: (MolForge compound catalog, from PubChem)
About 11-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]naphthalen-1-yl]-4-phenylindolo[2,1-b][1,3]benzothiazole
11-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]naphthalen-1-yl]-4-phenylindolo[2,1-b][1,3]benzothiazole (PubChem CID 164782197) has the molecular formula C51H32N4S and a molecular weight of 732.91 g/mol. Its IUPAC name is 11-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]naphthalen-1-yl]-4-phenylindolo[2,1-b][1,3]benzothiazole.
Molecular Properties
| Compound Name | 11-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]naphthalen-1-yl]-4-phenylindolo[2,1-b][1,3]benzothiazole |
|---|---|
| PubChem CID | 164782197 |
| Molecular Formula | C51H32N4S |
| Molecular Weight | 732.91 g/mol |
| Exact Mass | 732.23 |
| IUPAC Name | 11-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]naphthalen-1-yl]-4-phenylindolo[2,1-b][1,3]benzothiazole |
| SMILES | c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc(-c5c6cccc(-c7ccccc7)c6n6c5sc5ccccc56)c5ccccc45)cc3)n2)cc1 |
| InChI | InChI=1S/C51H32N4S/c1-4-15-33(16-5-1)39-23-14-24-43-46(51-55(47(39)43)44-25-12-13-26-45(44)56-51)42-32-31-38(40-21-10-11-22-41(40)42)34-27-29-37(30-28-34)50-53-48(35-17-6-2-7-18-35)52-49(54-50)36-19-8-3-9-20-36/h1-32H |
| InChIKey | PLYYBVTTWOVFKJ-UHFFFAOYSA-N |
| XLogP | 13.65 |
| TPSA | 43.08 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 56 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 732.91 |
| LogP ≤ 5 | 13.65 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164782197 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.